Immediate Impact

19 standout
Sub-graph 1 of 8

Citing Papers

Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
New advances in type 1 diabetes
2024 Standout
2 intermediate papers

Works of Sofia Keim being referenced

Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)
2017
Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis
2016

Author Peers

Author Last Decade Papers Cites
Sofia Keim 141 17 56 56 10 249
Hèlen Koch 108 8 28 52 15 290
Katharina Lau 31 12 136 23 11 259
Oren Steen 22 4 28 6 12 294
Sonja K. Fredrickson 152 5 30 14 9 278
Lijuan Fu 47 2 91 5 20 240
D. van Dijk 134 4 26 20 12 204
Areeg Bala 74 10 20 3 16 263
R. Palmer 171 4 23 13 10 292
Erik Kelly 35 4 12 9 10 294
Mohammed Alawami 94 4 9 7 13 225

All Works

Loading papers...

Rankless by CCL
2026